Should Acetazolamide Be the First-Line Treatment for Patients with Idiopathic Intracranial Hypertension?

David I. Kaufman; Deborah I. Friedman

doi:10.1097/WNO.0000000000000513

Should Acetazolamide Be the First-Line Treatment for Patients with Idiopathic Intracranial Hypertension?

David I. Kaufman, Deborah I. Friedman

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	182-186
Number of pages	5
Journal	Journal of Neuro-Ophthalmology
Volume	37
Issue number	2
DOIs	https://doi.org/10.1097/WNO.0000000000000513
State	Published - Jun 1 2017

ASJC Scopus subject areas

Ophthalmology
Clinical Neurology

Access to Document

10.1097/WNO.0000000000000513

Cite this

@article{84d62c0b348c4b459d5b3c83f10c6e0d,

title = "Should Acetazolamide Be the First-Line Treatment for Patients with Idiopathic Intracranial Hypertension?",

author = "Kaufman, {David I.} and Friedman, {Deborah I.}",

year = "2017",

month = jun,

day = "1",

doi = "10.1097/WNO.0000000000000513",

language = "English (US)",

volume = "37",

pages = "182--186",

journal = "Journal of Neuro-Ophthalmology",

issn = "1070-8022",